Literature DB >> 16482683

The Kramer-Pollnow syndrome: a contribution on the life and work of Franz Kramer and Hans Pollnow.

Klaus-Jürgen Neumärker1.   

Abstract

In 1932 Franz Kramer (1887-1967) and Hans Pollnow (1902-43) described a hyperkinetic syndrome in children. Basically the symptoms described coincide with what is nowadays regarded as Attention Deficit Hyperactivity Disorder (ADHD) or Hyperkinetic syndrome. The authors of the study thus went down in the history of child and adolescent psychiatry with their eponymous Kramer-Pollnow syndrome, and have had a lasting influence on the development of the concepts relating to this topic. Both worked together at the psychiatric and neurological hospital at Berlin's Charité under its head Karl Bonhoeffer, but as they were both Jewish they were forced to emigrate after the Nazis seized power. Until now, little has been known about the further fate and careers, so this study gives the first comprehensive account of their lives, based on documents found in the archives. It also presents an overview of their work.

Entities:  

Mesh:

Year:  2005        PMID: 16482683     DOI: 10.1177/0957154X05054708

Source DB:  PubMed          Journal:  Hist Psychiatry        ISSN: 0957-154X


  3 in total

1.  [Fredy Quadfasel (1902-1981) : Neuropsychiatrist, politically persecuted NS opponent and his impact in American exile].

Authors:  K-J Neumärker; B Holdorff
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

Review 2.  ["… no reservations against the dismissals": the expulsion of neuroscientists from Berlin].

Authors:  Michael Martin; Axel Karenberg; Heiner Fangerau
Journal:  Nervenarzt       Date:  2022-10-05       Impact factor: 1.297

Review 3.  The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.

Authors:  Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang
Journal:  Neurosci Biobehav Rev       Date:  2021-02-04       Impact factor: 9.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.